Amgen posted strong earnings beat and has an attractive dividend, and technical chart forecasting positive future performance ...

Equip Exposition, the international landscape, outdoor living, and equipment exposition, announces housing blocks have opened for industry members wishing to attend the 2025 show. Louisville Tourism ...

FaceTec announced a key addition to its executive team, Nicole McNamee-Wicks, Director of Biometric Cybersecurity, as the company expands its industry-leading position in global 3D Face Verification, ...

Cell and Gene Therapy Market 2025 Cell and Gene Therapy Market is estimated to be valued at US$ 22.7 bn in 2023 and is expected to exhibit a CAGR of 28.7% during the forecast period 2023-2030 BURLINGA ...

Amgen is a biotechnology leader with competitive advantages in scale, R&D, manufacturing efficiency, and distribution, bolstered by a robust pipeline and rising margins. I currently rate Amgen as ...

MariTide Phase 3 studies to begin in first half of year FDA places hold on AMG 513 obesity drug trial Amgen's Q4 earnings beat estimates, revenue up 11% Feb 4 (Reuters) - Amgen (AMGN.O), opens new ...

Free cash flow surged to $4.4 billion, up a remarkable 1,367% year over year. Amgen reported strong fourth-quarter earnings, driven by strategic acquisitions and robust product sales growth.

Biotechnology specialist Amgen (NASDAQ:AMGN) reported fourth-quarter and full-year 2024 earnings on Tuesday, Feb. 4, that topped analysts' consensus estimates. Analysts estimated Q4 adjusted EPS ...

Less than a decade since it secured its first FDA approval for a biosimilar, Amgen’s portfolio of the copycat drugs is growing and making strong contributions to the company’s top line.

RBC Capital analyst Gregory Renza maintained a Buy rating on Amgen (AMGN – Research Report) yesterday and set a price target of $320.00. The company’s shares closed yesterday at $289.02.

My name is Julianne, and I will be your conference facilitator today for Amgen's fourth quarter and full year 2024 financial results conference call. All lines have been placed on mute to prevent ...